Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Unigene Lab. (UGNE) -- Ignore unavailable to you. Want to Upgrade?

To: Amy2D who wrote (320)	6/10/1999 3:07:00 PM
From: Guy Costa	Read Replies (1) \| Respond to of 347

Recent flurry WLA/Yahoo related?? Hi Amy I suspect some of the recent activity was spec buying derived from bullish statements re: oral calcitonin on the WLA Yahoo Board. (For example messages.yahoo.com Folks probably figured, what the hell, under a buck I'll buy some. I watch real -time trades and did not see too many large blocks (10k or better) which further gives me the feeling of a flurry of retail spec buying. The lack of follow through as it punched through a buck is not encouraging. I tend to agree with "biobeliever" who responded to your Yahoo post. UGNE does indeed suffer from a lack of street sponsorship. Their attempts in recent years to use financial PR firms were a bust. Unfortunately, the Levy's play it almost like a closed Corp. resulting in poor investor relations strategies. In the long run, however, it is the product development strategy that will pay off for all of us. But right now, investors essentially must put blind faith to work in holding on. I would sure like to hear, for instance, from a WLA rep. regarding WLA's view of the joint effort, where it stands, are they on target, is there a high confidence level that oral formulation will be commercialized and when? Meanwhile, will look for those announcements. Take care Guy